awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35837560-26D78C75-6B6F-4C3F-BC85-ACC53D1BBA86
Q35837560-26D78C75-6B6F-4C3F-BC85-ACC53D1BBA86
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35837560-26D78C75-6B6F-4C3F-BC85-ACC53D1BBA86
Bevacizumab reduces the growth rate constants of renal carcinomas: a novel algorithm suggests early discontinuation of bevacizumab resulted in a lack of survival advantage.
P2860
Q35837560-26D78C75-6B6F-4C3F-BC85-ACC53D1BBA86
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35837560-26D78C75-6B6F-4C3F-BC85-ACC53D1BBA86
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ab004e7cb3428345f611350f43ba109e369c9e65
P2860
Molecular pathways and the hope of targeting angiogenesis.